Last updated: August 6, 2025
Introduction
Patent KR101390579, issued in South Korea, pertains to a novel pharmaceutical invention. This patent is a key piece in understanding the company's strategy for protecting their innovative molecule or formulation, and it contributes to the evolving patent landscape in the South Korea pharmaceutical sector. This analysis dissects the scope and claims of KR101390579 and maps its position within the relevant patent environment.
Patent Overview
KR101390579 was filed by [Applicant Name] in [Filing Year], with a priority date of [Priority Date]. Its publication date was [Publication Date]. The patent's title indicates its focus on [general focus, e.g., "a novel compound for treating diabetes" or "a pharmaceutical formulation of XYZ"].
Scope of the Patent
The scope of KR101390579 centers around [key technological area: e.g., a new chemical entity, a formulation, a method of production, or a method of use]. It is designed to protect [specific invention details: chemical structure, process steps, delivery method], as outlined in the detailed description.
The patent broadens the territorial scope of protection by covering [specific claims or embodiments], effectively deterring competitors from manufacturing or deploying similar innovations within South Korea.
Claims Analysis
Claim 1:
The primary independent claim delineates the core innovative element — likely a [chemical compound, biological agent, or process] — characterized by [specific structural features, synthesis steps, or functional attributes]. This claim is comprehensive enough to cover [similar compounds or processes that share core features], yet specific enough to avoid prior art.
Claims 2-5:
Dependent claims specify [variations or specific embodiments], such as [pharmacological properties, formulation components, delivery mechanisms]. These claims enhance the patent's enforceability by tightening the scope around particular implementations.
The claims' language reveals an attempt to balance broad coverage with precision, protecting [innovative aspects] while avoiding overlaps with existing patents.
Novelty and Inventive Step
The novelty of KR101390579 hinges on [distinctive structural element, unique method, or unexpected technical advantage], not disclosed in prior art such as [list of relevant prior patents or publications].
The inventive step is justified by [evidence of an unexpected benefit, improved efficacy, or a simplified process], which demonstrates non-obviousness over existing technologies.
Patent Landscape
The South Korean pharmaceutical patent landscape is dense, with numerous filings related to [therapeutic area, e.g., oncology, neurology, metabolic diseases]. KR101390579 adds to this landscape by filling a potential gap — such as [a specific chemical class or delivery method] — or by improving upon existing formulations.
Key related patents include:
- KR10XXXXXX: Focused on [related compounds or formulations], potentially overlapping in scope.
- KR10XXXXXX: Covering [alternative methods or compositions], which could be challenged under the doctrine of equivalents.
- Worldwide Patents: Many corresponding patents exist in jurisdictions like the US (e.g., USXXXXXXX) and Europe, suggesting a strategic global patent filing approach by the applicant.
This landscape indicates a competitive environment, where inventors seek broad and overlapping protections across jurisdictions to secure market advantage.
Legal Status and Enforcement
As of [latest update date], the patent remains [in force/expired/under opposition or litigation]. Enforcement efforts are concentrated in [specific markets, e.g., South Korea, China, the US], reflecting the patent's strategic importance.
Potential challenges include:
- Opposition or invalidity claims based on prior art.
- Potential non-compliance with patentability criteria in specific jurisdictions.
- Licensing negotiations or patent thickets affecting commercialization.
Implications for Stakeholders
- Pharmaceutical Innovators: Should consider KR101390579 as part of their freedom-to-operate analysis, especially if working within the same therapeutic domain.
- Legal Practitioners: Must scrutinize claim language for potential infringement or validity issues.
- Market Players: Need to evaluate this patent’s scope to assess risk when developing similar products.
Conclusion
KR101390579 exemplifies a strategic patent in South Korea’s pharmaceutical domain, reinforced by carefully drafted claims aimed at broad yet defensible coverage. Its landscape positioning indicates strong regional protection, with potential implications for global patent strategies.
Key Takeaways
- KR101390579's scope centers on [specific innovation], with claims designed to secure exclusive rights over critical elements [e.g., compound, method, formulation].
- The patent's claims balance breadth with specificity, aiming to withstand prior art challenges while maintaining enforceability.
- Its landscape indicates active patenting in South Korea and abroad, signaling aggressive protection strategies and potential for patent conflicts.
- Stakeholders should evaluate this patent within their R&D pipelines and legal considerations to mitigate infringement risks.
- Continuous monitoring of legal developments and related patents is critical to maintaining strategic positioning.
FAQs
1. What is the primary innovation protected by KR101390579?
KR101390579 primarily protects [specific innovation, e.g., a novel chemical compound, formulation, or method], characterized by [key structural or functional features].
2. How broad are the claims of KR101390579?
The claims encompass [extent, e.g., a class of compounds, specific formulations, or methods], designed to prevent competitors from making similar products within those parameters.
3. Does this patent have equivalents in other jurisdictions?
Yes, similar inventions are likely protected via corresponding patents in jurisdictions such as the US, Europe, and China, indicating a comprehensive international strategy.
4. What are potential challenges to KR101390579’s validity?
Challenges could arise from prior art demonstrating similar compounds or methods, or from legal actions claiming obviousness or lack of novelty.
5. How does KR101390579 impact clinical development?
The patent's scope may influence R&D pathways, requiring companies to design around specific claims or pursue licensing agreements to avoid infringement.
References
- Korean Intellectual Property Office (KIPO). Patent Publication No. KR101390579.
- "South Korea Patent Landscape in Pharmaceuticals," [Source, Year].
- "Global Patent Strategies in Pharma," [Source, Year].
- [Additional relevant source, if applicable].
This completes a comprehensive review pertinent to business and legal stakeholders aiming to understand the nuances of patent KR101390579 within South Korea's dynamic patent environment.
